Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
brets@coreir.com
Sigma Labs, Inc.
Condensed Balance Sheets
(Unaudited)
| June 30, 2018 | December 31, 2017 | ||||||
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash | $ | 3,519,637 | $ | 1,515,674 | |||
| Accounts Receivable, net | 63,510 | 104,538 | |||||
| Note Receivable, net | 118,164 | 788,500 | |||||
| Inventory | 145,605 | 192,705 | |||||
| Prepaid Assets | 64,891 | 55,278 | |||||
| Total Current Assets | 3,911,807 | 2,656,695 | |||||
| Other Assets: | |||||||
| Property and Equipment, net | 358,686 | 411,643 | |||||
| Intangible Assets, net | 317,161 | 294,396 | |||||
| Investment in Joint Venture | 500 | 500 | |||||
| Prepaid Stock Compensation | 130,965 | 31,576 | |||||
| Total Other Assets | 807,312 | 738,115 | |||||
| TOTAL ASSETS | $ | 4,719,119 | $ | 3,394,810 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current Liabilities: | |||||||
| Accounts Payable | $ | 288,379 | $ | 100,884 | |||
| Dividends Payable | 15,125 | - | |||||
| Notes Payable | 50,000 | 100,000 | |||||
| Deferred Revenue | 69,706 | 35,680 | |||||
| Accrued Expenses | 168,095 | 146,330 | |||||
| Total Current Liabilities | 591,305 | 382,894 | |||||
| TOTAL LIABILITIES | 591,305 | 382,894 | |||||
| Commitments & Contingencies | |||||||
| Stockholders’ Equity | |||||||
| Preferred Stock, $0.001 par; 10,000,000 shares authorized; 350 and 0 shares issued and outstanding, respectively | - | - | |||||
| Common Stock, $0.001 par; 15,000,000 shares authorized; 8,248,729 and 4,978,929 issued and outstanding, respectively | 8,249 | 4,979 | |||||
| Additional Paid-In Capital | 20,879,827 | 17,192,394 | |||||
| Accumulated Deficit | (16,760,262 | ) | (14,185,457 | ) | |||
| Total Stockholders’ Equity | 4,127,814 | 3,011,916 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 4,719,119 | $ | 3,394,810 | |||
Sigma Labs, Inc.
